Literature DB >> 17003058

Norwood procedure for hypoplastic left heart syndrome: BT shunt or RV-PA conduit?

Linda Edwards1, Kevin P Morris, Ameen Siddiqui, Deborah Harrington, David Barron, William Brawn.   

Abstract

BACKGROUND: The Norwood procedure is the first stage palliative procedure for hypoplastic left heart syndrome (HLHS). Traditionally the pulmonary circulation has been supplied via a modified Blalock Taussig (BT) shunt but a recent modification, adopted in some UK centres, substitutes a conduit between right ventricle and pulmonary arteries (RV-PA conduit). It is argued that this will result in a more favourable balance between pulmonary and systemic circulations. AIM: To compare the early postoperative haemodynamic profile between patients undergoing a BT shunt or an RV-PA conduit.
METHODS: Retrospective review in a tertiary referral PICU of 51 children with HLHS undergoing the Norwood procedure with either a BT shunt (Group 1; n = 23) or an RV-PA conduit (Group 2; n = 28). Data items were extracted at 10 set time points in the initial 96 h, postoperatively.
RESULTS: Diastolic BP was significantly lower in Group 1 (p<0.001) with a trend towards a higher systolic BP and no difference in mean BP. No between-group differences were found in markers of pulmonary blood flow (PaO2, PaCO2, PaO2/FiO2 ratio), or in markers of systemic blood flow (blood lactate, oxygen extraction ratio), or in estimated ratio of pulmonary:systemic blood flow (Qp:Qs). Despite lower diastolic blood pressure in Group 1 renal and hepatic function did not differ over five post-operative days between groups.
CONCLUSIONS: With the exception of a higher diastolic blood pressure in the RV-PA conduit group, we found no difference in the early haemodynamic profile between patients undergoing an RV-PA conduit or a BT shunt.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003058      PMCID: PMC2675331          DOI: 10.1136/adc.2006.094664

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  21 in total

1.  Venous saturation and the anaerobic threshold in neonates after the Norwood procedure for hypoplastic left heart syndrome.

Authors:  G M Hoffman; N S Ghanayem; J M Kampine; S Berger; K A Mussatto; S B Litwin; J S Tweddell
Journal:  Ann Thorac Surg       Date:  2000-11       Impact factor: 4.330

2.  Right ventricle-to-pulmonary artery shunt versus modified Blalock-Taussig shunt in the Norwood procedure for hypoplastic left heart syndrome - influence on early and late haemodynamic status.

Authors:  Edward Malec; Katarzyna Januszewska; Jacek Kolcz; Tomasz Mroczek
Journal:  Eur J Cardiothorac Surg       Date:  2003-05       Impact factor: 4.191

3.  Impact of inspired gas mixtures on preoperative infants with hypoplastic left heart syndrome during controlled ventilation.

Authors:  S Tabbutt; C Ramamoorthy; L M Montenegro; S M Durning; C D Kurth; J M Steven; R I Godinez; T L Spray; G Wernovsky; S C Nicolson
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

4.  Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. Prophylactic Intravenous Use of Milrinone After Cardiac Operation in Pediatrics.

Authors:  Timothy M Hoffman; Gil Wernovsky; Andrew M Atz; James M Bailey; Akbar Akbary; John F Kocsis; David P Nelson; Anthony C Chang; Thomas J Kulik; Thomas L Spray; David L Wessel
Journal:  Am Heart J       Date:  2002-01       Impact factor: 4.749

5.  Right ventricle to pulmonary artery conduit improves outcome after stage I Norwood for hypoplastic left heart syndrome.

Authors:  Christian Pizarro; Edward Malec; Kevin O Maher; Katarzyna Januszewska; Samuel S Gidding; Kenneth A Murdison; Jeanne M Baffa; William I Norwood
Journal:  Circulation       Date:  2003-09-09       Impact factor: 29.690

6.  Evolving strategies and improving outcomes of the modified norwood procedure: a 10-year single-institution experience.

Authors:  T Azakie; S L Merklinger; B W McCrindle; G S Van Arsdell; K J Lee; L N Benson; J G Coles; W G Williams
Journal:  Ann Thorac Surg       Date:  2001-10       Impact factor: 4.330

7.  Right ventricular to pulmonary artery conduit instead of modified Blalock-Taussig shunt improves postoperative hemodynamics in newborns after the Norwood operation.

Authors:  Rudolf Mair; Gerald Tulzer; Eva Sames; Roland Gitter; Evelyn Lechner; Jürgen Steiner; Anna Hofer; Gertraud Geiselseder; Christoph Gross
Journal:  J Thorac Cardiovasc Surg       Date:  2003-11       Impact factor: 5.209

8.  Hemodynamic profile after the Norwood procedure with right ventricle to pulmonary artery conduit.

Authors:  Kevin O Maher; Christian Pizarro; Samuel S Gidding; Katarzyna Januszewska; Edward Malec; William I Norwood; John D Murphy
Journal:  Circulation       Date:  2003-08-11       Impact factor: 29.690

9.  Right ventricle-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome.

Authors:  Shunji Sano; Kozo Ishino; Masaaki Kawada; Sadahiko Arai; Shingo Kasahara; Tomohiro Asai; Zen-ichi Masuda; Mamoru Takeuchi; Shin-ichi Ohtsuki
Journal:  J Thorac Cardiovasc Surg       Date:  2003-08       Impact factor: 5.209

10.  Right ventricle to pulmonary artery conduit has a favorable impact on postoperative physiology after Stage I Norwood: preliminary results.

Authors:  Christian Pizarro; William I Norwood
Journal:  Eur J Cardiothorac Surg       Date:  2003-06       Impact factor: 4.191

View more
  1 in total

Review 1.  Hypoplastic left heart syndrome: current considerations and expectations.

Authors:  Jeffrey A Feinstein; D Woodrow Benson; Anne M Dubin; Meryl S Cohen; Dawn M Maxey; William T Mahle; Elfriede Pahl; Juan Villafañe; Ami B Bhatt; Lynn F Peng; Beth Ann Johnson; Alison L Marsden; Curt J Daniels; Nancy A Rudd; Christopher A Caldarone; Kathleen A Mussatto; David L Morales; D Dunbar Ivy; J William Gaynor; James S Tweddell; Barbara J Deal; Anke K Furck; Geoffrey L Rosenthal; Richard G Ohye; Nancy S Ghanayem; John P Cheatham; Wayne Tworetzky; Gerard R Martin
Journal:  J Am Coll Cardiol       Date:  2012-01-03       Impact factor: 24.094

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.